Johannes H. M. Merks

Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands

Johanna M. Meulepas, Cécile M. Ronckers, Anne Smets et al. · JNCI Journal of the National Cancer Institute · 2018 · 349 citations · Full text

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron et al. · The Lancet Oncology · 2019 · 231 citations · Full text

Oncology, Metronomic Therapy, Rms 2005 +9

Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study

Odile Oberlin, Annie Rey, Joan Sánchez-de-Toledo et al. · Journal of Clinical Oncology · 2012 · 188 citations · Full text

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Gianni Bisogno, Meriel Jenney, Christophe Bergeron et al. · The Lancet Oncology · 2018 · 182 citations

Oncology, Medicine, Dose-intensified Doxorubicin +10

Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)

Andrea Ferrari, Gian Luca De Salvo, Bernadette Brennan et al. · Annals of Oncology · 2014 · 152 citations

Synovial Sarcoma, Childhood Arthritis, Pediatrics +4